Drugs / TNFa Kinoid
TNFa Kinoid
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT00808262 | Oct 2008 → Dec 2010 | Crohn disease | Neovacs | Completed | No outcome recorded |
| Phase 21 trial · 1 missed | ||||||
| Phase 2 | NCT01040715 | Dec 2009 → Oct 2012 | rheumatoid arthritis | Neovacs | Completed | Missed primary |
Evidence & citations 8 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TNFa Kinoid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01040715 ↗ |
| Known as | TNF- K | “TNFα-Kinoid (TNF- K)” NCT00808262 ↗ |
| Known as | TNF-Kinoid | “Biological: TNF kinoid” NCT01040715 ↗ |
| Known as | TNFα-Kinoid | “TNFα-Kinoid (TNF- K)” NCT00808262 ↗ |
| Action | Inhibit | “induce polyclonal anti-TNF antibodies” PMID 25517733 ↗ Dec 2014 |
| Modality | Vaccine | “active immunization through a TNFa kinoid” NCT00808262 ↗ |
| Route | Intramuscular | “Patients were immunized intramuscularly” PMID 25517733 ↗ Dec 2014 |
| Target | TNF | “anti-TNF antibodies” PMID 25517733 ↗ Dec 2014 |